Dr. Jeffrey Ward, M.D., Ph.D.
Claim this profileWashington University School of Medicine
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
8 reported clinical trials
16 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
EGFR positive
2Non-Small Cell Lung Cancer
Stage III
Stage IV
EGFR positive
Affiliated Hospitals
Clinical Trials Jeffrey Ward, M.D., Ph.D. is currently running
More about Jeffrey Ward, M.D., Ph.D.
Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 1 Active Clinical TrialTreatments Jeffrey Ward, M.D., Ph.D. has experience with
- Durvalumab
- Personalized Neoantigen Vaccine
- Pembrolizumab
- Anetumab Ravtansine
- ITIL-306
- ITIL-168
Breakdown of trials Jeffrey Ward, M.D., Ph.D. has run
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Squamous Cell Carcinoma
Cervical Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Jeffrey Ward, M.D., Ph.D. specialize in?
Is Jeffrey Ward, M.D., Ph.D. currently recruiting for clinical trials?
Are there any treatments that Jeffrey Ward, M.D., Ph.D. has studied deeply?
What is the best way to schedule an appointment with Jeffrey Ward, M.D., Ph.D.?
What is the office address of Jeffrey Ward, M.D., Ph.D.?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.